🇺🇸 FDA
Drug

nipocalimab-aahu

Brand: IMAAVY

approved

Quick answer

nipocalimab-aahu (IMAAVY), is a pharmaceutical active ingredient, with approved status in the US.

Key facts

INN
nipocalimab-aahu
Brand
IMAAVY
Route
INJECTION
Formulation
INJECTABLE

Related news

FDA Grants Priority Review for IMAAVY (Nipocalimab-aahu) as First Potential Treatment for Warm Autoimmune Hemolytic Anemia
NewsAutoimmune HematologyApr 28, 2026

FDA Grants Priority Review for IMAAVY (Nipocalimab-aahu) as First Potential Treatment for Warm Autoimmune Hemolytic Anemia

FDA grants Priority Review for IMAAVY (nipocalimab-aahu), potentially the first approved treatment for warm autoimmune hemolytic anemia (wAIHA).

Michael Rivera

Frequently asked questions

What is nipocalimab-aahu?

nipocalimab-aahu (IMAAVY), is a pharmaceutical active ingredient, with approved status in the US.

What is the brand name for nipocalimab-aahu?

IMAAVY is a marketed brand name for nipocalimab-aahu. Check FDA Drugs@FDA for the current US label holder.